257 Statutory Reports 24 - 109 Financial Statements 110 - 263 Corporate Overview 01 - 23 (` cr) Particulars Life Science Chemicals Performance and Other Chemicals Others Total 2021-22 2020-21 2021-22 2020-21 2021-22 2020-21 2021-22 2020-21 iii) Other information Segment assets 1,043.00 843.20 2,470.28 1,991.70 167.25 130.83 3,680.53 2,965.73 Unallocated common assets 2,025.82 1,971.47 Total assets 5,706.35 4,937.20 Segment liabilities 284.69 290.71 652.11 579.32 47.36 37.38 984.16 907.41 Unallocated common liabilities 262.35 172.64 Total liabilities 1,246.51 1,080.05 Additions to assets and intangible assets 105.85 52.95 524.12 247.58 6.79 3.17 636.76 303.70 Unallocated additions to assets and intangible assets 3.69 0.95 Total capital expenditure* 640.45 304.65 Depreciation 45.96 39.94 123.05 89.64 4.12 3.60 173.13 133.18 Unallocated depreciation 3.56 3.14 Total depreciation 176.69 136.32 c) Geographical segment (` cr) Particulars In India Outside India Total 2021-22 2020-21 2021-22 2020-21 2021-22 2020-21 Segment revenue 2,525.88 1,964.38 2,555.01 1,767.09 5,080.89 3,731.47 Carrying cost of assets by location of assets 5,343.32 4,636.70 363.03 300.50 5,706.35 4,937.20 Additions to assets and intangible assets* 640.45 304.65 - - 640.45 304.65 *Including capital work-in-progress and capital advances d) Revenue from major customers The Group is not reliant on revenues from transactions with any single external customer and does not receive 10% or more of its revenues from transactions with any single external customer. e) Other disclosures i) The Group has disclosed business segment as the operating segment, which has been identified in line with the Ind AS 108 ‘Operating Segments’ taking into account the organisation structure as well as the differing risks and returns. ii) The segment revenue, results, assets and liabilities include respective amounts identifiable to each segment and amounts allocated on a reasonable basis. iii) The Group accounts for inter-segment sales and transfers at market price. . Note 29.16 Segment information (continued)
RkJQdWJsaXNoZXIy MjA2MDI2